Generate Biomedicines
Recent Finacing
Equity
Recent Raise
Undisclosed
Generate Biomedicines uses a machine-learning-driven generate‑build‑measure‑learn platform to design and advance de novo proteins—antibodies, peptides, enzymes, and cell therapies—for oncology, immunology, and infectious disease.
